Iambic Announces Pricing of Initial Public Offering
Business Wire (AI)en
Business Wire (AI)
AI Global WireIambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven ...
This is a short summary published by AI Global Wire. The full article is owned and hosted by Business Wire (AI) — open it there to read it in full.
Read the full story at Business Wire (AI)Related AI news
- ScaleFlux bets its controller chips can break AI’s memory bottleneckSiliconANGLE · October 15, 2026
- Sources: Anthropic told investors that distillation accounts for 5% to 7% of revenue; its rapid but slowing revenue growth could weigh on its IPO valuation (Cory Weinberg/The Information)Techmeme · October 15, 2026
- Linux 將放棄強制標註使用 AI 工具，Linus Torvalds 稱這規定「很蠢」TechNews (TW) · October 15, 2026
- 輝達 5 年砸 2.5 億美元算力資源，助英國強化代理式 AI 安全研究TechNews (TW) · October 15, 2026
- AI 時代越滑越孤單？Twitch 執行長：直播的「共同體驗」才能留住人心TechNews (TW) · October 15, 2026
- Asian stocks plummet as AI debt and inflation fears biteNikkei Asia · October 15, 2026